OTLKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Outlook Therapeutics, Inc.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 18, 2026
$0.49+0.00 (+0.98%)
Close on Oct 19, 2026
- Market cap
- $67.41M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Mar 14, 2024 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Mar 14, 2024 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Mar 18, 2019 | 1-for-8 reverse | Earlier per-share figures multiplied by 8 |
| Mar 15, 2019 | 1-for-8 reverse | Earlier per-share figures multiplied by 8 |